Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Hansmann

Showing results (191-200 of 259) with videos related to

Pageof 26
Sort By:
Blood|March 28, 2014
The enhancer and promoter landscape of human regulatory and conventional T-cell subpopulationsChristian Schmidl, Leo Hansmann, Timo Lassmann, et al.
Leukemia & Lymphoma|December 27, 2021
Loss of function mutations of <i>BCOR</i> in classical Hodgkin lymphomaMaciej Giefing, Micah D Gearhart, Markus Schneider, et al.
Leukemia|July 16, 2025
Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencingTobias Rausch, Hendrik Schäfer, Julia Bein, et al.
Cancers|October 23, 2021
Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin LymphomasSylvia Hartmann, Sonja Scharf, Yvonne Steiner, et al.
American Journal of Hematology|August 10, 2019
The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphomaSylvia Hartmann, Annette Plütschow, Anja Mottok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study GroupWolfram Klapper, Eva Hoster, Lars Rölver, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 19, 2025
Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorderHelena Hansmann, Chiara Henkel, Matthias A Fante, et al.
British Journal of Haematology|January 26, 2005
The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomasTeresa Marafioti, Teresa Marafiot, Michela Pozzobon, et al.
Blood|September 15, 2005
Transmembrane adaptor molecules: a new category of lymphoid-cell markersSara Tedoldi, Jennifer C Paterson, Martin-Leo Hansmann, et al.
British Journal of Haematology|June 27, 2014
Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG)Sylvia Hartmann, Dennis A Eichenauer, Annette Plütschow, et al.
Pageof 26

Showing results (191-200 of 259) with videos related to

Sort By:
Pageof 26
Blood|March 28, 2014
The enhancer and promoter landscape of human regulatory and conventional T-cell subpopulationsChristian Schmidl, Leo Hansmann, Timo Lassmann, et al.
Leukemia & Lymphoma|December 27, 2021
Loss of function mutations of <i>BCOR</i> in classical Hodgkin lymphomaMaciej Giefing, Micah D Gearhart, Markus Schneider, et al.
Leukemia|July 16, 2025
Genetic lesions in nodular lymphocyte-predominant Hodgkin lymphoma and T cell/histiocyte-rich large B-cell lymphoma identified by whole genome sequencingTobias Rausch, Hendrik Schäfer, Julia Bein, et al.
Cancers|October 23, 2021
Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin LymphomasSylvia Hartmann, Sonja Scharf, Yvonne Steiner, et al.
American Journal of Hematology|August 10, 2019
The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphomaSylvia Hartmann, Annette Plütschow, Anja Mottok, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study GroupWolfram Klapper, Eva Hoster, Lars Rölver, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 19, 2025
Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorderHelena Hansmann, Chiara Henkel, Matthias A Fante, et al.
British Journal of Haematology|January 26, 2005
The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomasTeresa Marafioti, Teresa Marafiot, Michela Pozzobon, et al.
Blood|September 15, 2005
Transmembrane adaptor molecules: a new category of lymphoid-cell markersSara Tedoldi, Jennifer C Paterson, Martin-Leo Hansmann, et al.
British Journal of Haematology|June 27, 2014
Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG)Sylvia Hartmann, Dennis A Eichenauer, Annette Plütschow, et al.
Pageof 26